n-(3-(aminomethyl)benzyl)acetamidine has been researched along with Vascular Diseases in 1 studies
N-(3-(aminomethyl)benzyl)acetamidine: structure in first source
N-[3-(aminomethyl)benzyl]acetamidine : An aralkylamine that is Nbenzylacetamidine substituted at position 3 on the benzene ring by an aminomethyl group. An inhibitor of nitric oxide synthase.
Vascular Diseases: Pathological processes involving any of the BLOOD VESSELS in the cardiac or peripheral circulation. They include diseases of ARTERIES; VEINS; and rest of the vasculature system in the body.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nagareddy, PR | 1 |
| Xia, Z | 1 |
| McNeill, JH | 1 |
| MacLeod, KM | 1 |
1 other study available for n-(3-(aminomethyl)benzyl)acetamidine and Vascular Diseases
| Article | Year |
|---|---|
Increased expression of iNOS is associated with endothelial dysfunction and impaired pressor responsiveness in streptozotocin-induced diabetes.
Topics: Amidines; Angiotensin II; Animals; Benzylamines; Blood Pressure; Blotting, Western; Diabetes Mellitu | 2005 |